Study: Blood thinner safe for cancer patients with brain metastases
2015-05-18
(Press-News.org) (WASHINGTON, May, 18, 2015) - Cancer patients with brain metastases who develop blood clots may safely receive blood thinners without increased risk of dangerous bleeding, according to a study, published online today in Blood, the Journal of the American Society of Hematology
Cancer increases a patient's risk of developing blood clots. When a patient with cancer develops a clot, treatment with a blood thinning medication called an anticoagulant is often added to their treatment regimen in order to prevent the potentially fatal complication of blood clots traveling to the lungs. However, if cancer spreads to the brain, anticoagulant treatment may be withheld because it could cause dangerous bleeding in the patient's head, which is already a risk for these patients. The task of preventing dangerous blood clots and avoiding life-threatening bleeding presents a particular challenge for specialists in patients with tumor metastases in the brain. Until recently, no data had confirmed whether blood thinners could be safely administered in these patients.
In order to determine whether administering blood-thinning medication to patients with brain metastases and blood clots increases bleeding, researchers studied the medical records of 293 patients, 104 of whom had received a widely used blood thinner (enoxaparin). The remaining 189 patients did not receive blood-thinning treatment. Researchers matched the patients in each group by year of brain metastases diagnosis, tumor type, age, and gender.
Based on their reviews of patients' medical records, researchers determined that there was no significant difference in the risk of bleeding between the patients who received enoxaparin and those who did not after 12 months. Cumulative incidence of bleeding in the head was 44 percent in the enoxaparin group versus 37 percent in the group that did not receive treatment. Regardless of treatment with enoxaparin, investigators observed a high bleeding rate among all patients with brain metastases (between 20-50%), consistent with the notion that bleeding is more common than originally thought.
"While it is a very common clinical scenario to treat a patient with a metastatic brain tumor who also develops a blood clot, before this study there was very little data to inform the difficult decision of whether or not to anticoagulate these patients," said senior study author Jeffrey Zwicker, MD, of Beth Israel Deaconess Medical Center and Harvard Medical School. "Our findings, which demonstrate that current practice is safe, should reassure physicians that anticoagulants can be safely administered to patients with brain metastases and a history of blood clots."
INFORMATION:
Blood, the most cited peer-reviewed publication in the field of hematology, is available weekly in print and online. Blood is the official journal of the American Society of Hematology (ASH), the world's largest professional society concerned with the causes and treatment of blood disorders.
ASH's mission is to further the understanding, diagnosis, treatment, and prevention of disorders affecting blood, bone marrow, and the immunologic, hemostatic, and vascular systems by promoting research, clinical care, education, training, and advocacy in hematology.
Blood® is a registered trademark of the American Society of Hematology
ELSE PRESS RELEASES FROM THIS DATE:
2015-05-18
In recent years, the popularity of "electronic dance music" (EDM) and dance festivals has increased substantially throughout the US and worldwide.
Even though data from national samples suggests drug use among adolescents in the general US population has been declining, targeted samples have shown nightclub attendees tend to report high rates of drug use, above that of the general population. In spite of increasing deaths among dance festival attendees in recent years, no nationally representative studies have examined potential associations between nightlife attendance ...
2015-05-18
MAYWOOD, IL - As many as 12 percent of patients undergoing major, non-cardiac surgery experience an irregular heartbeat called atrial fibrillation.
Post-operative atrial fibrillation (POAF) often is dismissed as a transient phenomenon. But a Loyola University Medical Center study has found that POAF can significantly increase the risk of heart attack or stroke during the first 12 months after surgery.
Among bladder cancer patients who underwent a cystectomy (bladder removal) and developed POAF, 24.8 percent experienced a heart attack or stroke during the first 12 months ...
2015-05-18
ATS 2015, DENVER ? Severe obstructive sleep apnea (OSA) and excessive daytime sleepiness are associated with an increased risk of depression in men, according to a new community-based study of Australian men, which was presented at the 2015 American Thoracic Society International Conference.
"An association between sleep apnea and depression has been noted in some earlier studies," said lead author Carol Lang, PhD, from the University of Adelaide, Australia. "Our study, in a large community-based sample of men, confirms a strong relationship even after adjustment for ...
2015-05-18
New York, NY, May 18, 2015 -- The National Cancer Institute (NCI) recently announced that it had removed all prostate specific antigen (PSA) data from the SEER (Surveillance, Epidemiology and End Results) and SEER-Medicare programs. The PSA data were removed after quality control checks revealed that a substantial number of PSA values included in the programs were incorrect. An editorial published in The Journal of Urology® explores the ramifications of the removal of these data for researchers, clinicians, and administrators within the health care community, as well ...
2015-05-18
Two studies from Johns Hopkins Kimmel Cancer Center researchers add to preliminary evidence that high-dose radiation treatment, called stereotactic body radiotherapy, appears to be safe and as effective as standard radiation treatment for certain patients with pancreatic cancer whose tumors are advanced but have not spread.
The studies also suggest, the researchers say, that stereotactic body radiotherapy (SBRT) may have some advantages over traditional radiation for some patients, because doses can be delivered over the course of one week, unlike six or seven weeks with ...
2015-05-18
Changing the size of cell-carrying spheres may surmount the difficulties that have bedeviled diabetes researchers trying to ferry insulin-producing islet cells into hosts as a way to treat type 1 diabetes.
New findings published in the journal Nature Materials suggest that for the spherical capsules, bigger may be better.
Tiny gel capsules carrying islet cells allow insulin to seep out, and nutrients to get in, through microscopic holes. The holes are small enough, however, to isolate and protect the encapsulated cells from the cells of host's immune system, which would ...
2015-05-18
CORVALLIS, Ore. -- Researchers at Oregon State University are pursuing a new concept in treatment of epithelial cancer, especially head and neck cancer, by using two promising "analogs" of an old compound that was once studied as a potent anti-tumor agent, but long ago abandoned because it was too toxic.
The analogs are more highly selective than the parent compound, pactamycin, which originally was found to kill all cells, from bacteria to mammals, by inhibiting their protein synthesis.
The pactamycin analogs, which were developed with biosynthetic engineering, also ...
2015-05-18
Largest study of its type shows people associate science with men in all 66 nations studied
Dominance of men in science stereotypes strongest in Scandinavian countries, especially the Netherlands
Gender-science stereotypes weaker in nations with more female scientists
Interactive table providing comprehensive rankings for all 66 nations
EVANSTON, Ill. --- The Netherlands had the strongest stereotypes associating science with men more than women, according to a new Northwestern University study that included data from nearly 350,000 people in 66 nations.
These ...
2015-05-18
Jumping spiders were already known to see in remarkably high resolution, especially considering that their bodies are less than a centimeter long. Now, researchers reporting in the Cell Press journal Current Biology on May 18 have figured out how spiders in the colorful genus Habronattus see in three color "channels," as most humans do.
"The eyes of jumping spiders could not be more different from those of butterflies or birds, and yet all three tune the color sensitivities using pigments that filter light," says Nathan Morehouse of the University of Pittsburgh. "It's ...
2015-05-18
Researchers have uncovered the first geologic evidence that New Zealand's southern Hikurangi margin can rupture during large earthquakes. The two earthquakes took place within the last 1000 years, and one was accompanied by a tsunami, according to the study published in the Bulletin of the Seimological Society of America (BSSA).
The earthquakes took place roughly 350 years apart, according to the analysis by Kate Clark of GNS Science and colleagues. This may mean that the time between large earthquakes in this region is shorter than scientists have thought. The current ...
LAST 30 PRESS RELEASES:
[Press-News.org] Study: Blood thinner safe for cancer patients with brain metastases
